8 insiders reported 36 Form 4 transactions for TENAX THERAPEUTICS, INC. (TENX) over the past 18 months (most recent 2026-09-17). Recent activity: Doogan Declan (Director) Buy 53,000 shares, STAAB THOMAS R II (Chief Financial Officer) Buy 5,675 shares, Giordano Christopher Thomas (CEO) Buy 6,000 shares, Giordano Christopher Thomas (CEO) Buy 4,850 shares, Schneeberger Daniel (10% Owner) Buy 900,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Doogan Declan | Director | Buy | 53,000 | $101,760 |
| 2026-09-15 | STAAB THOMAS R II | Chief Financial Officer | Buy | 5,675 | $10,981 |
| 2026-09-15 | Giordano Christopher Thomas | CEO | Buy | 6,000 | $11,250 |
| 2026-09-15 | Giordano Christopher Thomas | CEO | Buy | 4,850 | $8,837 |
| 2026-09-08 | Schneeberger Daniel | 10% Owner | Buy | 900,000 | $1.6M |
| 2026-09-08 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 900,000 | $1.6M |
| 2026-09-02 | Schneeberger Daniel | 10% Owner | Buy | 403,571 | $722,594 |
| 2026-09-02 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 403,571 | $722,594 |
| 2026-09-02 | Schneeberger Daniel | 10% Owner | Buy | 179,058 | $321,570 |
| 2026-09-02 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 179,058 | $321,570 |
| 2026-09-02 | Schneeberger Daniel | 10% Owner | Buy | 187,704 | $337,586 |
| 2026-09-02 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 187,704 | $337,586 |
| 2026-08-24 | Schneeberger Daniel | 10% Owner | Buy | 202,124 | $359,538 |
| 2026-08-24 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 202,124 | $359,538 |
| 2026-08-24 | Schneeberger Daniel | 10% Owner | Buy | 716,369 | $1.3M |
| 2026-08-24 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 716,369 | $1.3M |
| 2026-08-24 | Schneeberger Daniel | 10% Owner | Buy | 107,374 | $188,355 |
| 2026-08-24 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 107,374 | $188,355 |
| 2026-07-14 | Giordano Christopher Thomas | CEO | Buy | 219 | $777 |
| 2026-07-14 | Giordano Christopher Thomas | CEO | Buy | 8,500 | $50,490 |
| 2026-05-13 | STAAB THOMAS R II | Chief Financial Officer | Buy | 10,000 | $0 |
| 2025-12-10 | Rich Stuart | Chief Medical Officer | Buy | 2,500 | $25,250 |
| 2025-12-10 | Rich Stuart | Chief Medical Officer | Buy | 2,500 | $25,550 |
| 2025-12-05 | Rich Stuart | Chief Medical Officer | Buy | 1,000 | $9,010 |
| 2025-12-05 | Rich Stuart | Chief Medical Officer | Buy | 1,500 | $13,620 |
Source: SEC Form 4 filings · as of 2026-09-17